Omlyclo Disease Interactions
There is 1 disease interaction with Omlyclo (omalizumab).
Omalizumab (applies to Omlyclo) malignancies
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Skin Cancer, History - Skin Cancer
In clinical trials malignancies have been observed in patients receiving omalizumab. Periodic examination is recommended for all patients, particularly those with risk factors for cancer. Caution should be exercised when considering omalizumab for the treatment of patients with a history of malignancies, those who have a known malignancy, or when continuing treatment in patients who develop malignancy while receiving this agent.
Switch to professional interaction data
Omlyclo drug interactions
There are 32 drug interactions with Omlyclo (omalizumab).
Report options
More about Omlyclo (omalizumab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.